A Agilent Technologies Inc.

Agilent Wins Trade Secret and Patent Infringement Litigation

Agilent Technologies Inc. (NYSE: A) today announced it has won a judgement in federal court for patent infringement and trade secret misappropriation against Shanghai-based J&X Technologies. The court victory in the Northern District of Texas, Dallas Division, requires J&X to pay Agilent more than $1.25 million for illegally using Agilent patents and trade secrets in developing gas chromatography equipment.

The court victory also prevents J&X and its founders Xiaosheng Guan and Qiang Xu from manufacturing, distributing, or selling products using Agilent proprietary gas chromatography information. In addition, J&X is prohibited from disclosing or using Agilent gas chromatography information or other proprietary information. In its ruling, the Court noted that “J&X’s misappropriation of Agilent’s trade secrets was willful and malicious.”

“This court victory reinforces the critical importance Agilent places on protecting our intellectual property,” said Mike Tang, Agilent senior vice president and general counsel. “Innovation is central to what Agilent is all about and this court decision should stand as a message to those seeking to undermine our focus on innovation. We will always seek to protect our proprietary technology and the hard work of Agilent employees developing it to serve our customers.”

Gas chromatography is an analytical technique used to separate the chemical components of a sample mixture. It is used to detect what is in the mixture and how much of a given element or compound is present. Typical uses of gas chromatography include testing the purity of a particular substance or separating the different components of a mixture to understand how it is constituted.

Agilent has long been a leader in developing gas chromatography equipment. The company welcomes competition on its merits and looks forward to continuing to drive innovation in all areas of its business.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward improving the quality of life. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.34 billion in fiscal year 2020 and employs 16,400 people worldwide. Information about Agilent is available at . To receive the latest Agilent news, please subscribe to the Agilent . Follow Agilent on , , and .

EN
01/02/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agilent Technologies Inc.

Agilent Technologies, Inc.: Key facts and statistics - fiscal 2025

A summary company profile, detailing Agilent Technologies, Inc.’s business operations and financial highlights.

Agilent Technologies, Inc. - October 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Agilent Technologies, Inc.: Update to credit analysis

Our credit view of this issuer reflects its low financial leverage, against its high proportion of revenue from costly equipment sales, which has exposure to cyclical demand fluctuations

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Agilent Technologies, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 11 December 2025 in which we reassessed the appropriateness of the ratings in th...

Agilent Technologies Inc: 1 director

A director at Agilent Technologies Inc sold 2,600 shares at 149.812USD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch